# WHO approves trials for two new Ebola vaccines

- URL: https://talkfuse.com/story/who-approves-trials-for-two-new-ebola-vaccines/
- Published: 2026-11-04T19:22:09+00:00
- Updated: 2026-11-05T04:39:22+00:00
- Original publisher: Al Jazeera (publisher lean: Left)
- Original article: https://www.aljazeera.com/news/2026/11/4/who-approves-trials-for-two-new-ebola-vaccines?traffic_source=rss
- Topics: Health, Medicine, World

## Key points

- WHO approves trials of two vaccines targeting Bundibugyo Ebola.
- The outbreak has caused more than 5,300 deaths since May.
- Results are expected in early 2027.

## Summary

The WHO has approved clinical trials of two vaccines designed for the Bundibugyo strain of Ebola, as the Democratic Republic of the Congo faces its largest recorded outbreak. The strain has no vaccine or treatment developed specifically for it, and the WHO says the trial results could help address a disease with a reported fatality rate of 50 per cent.

A trial that began last month is using Ervebo, which was developed for the Zaire strain; results are expected in early 2027. The DRC’s National Institute for Biomedical Research is leading the work with WHO and other partners, with vaccine development involving Oxford, the Serum Institute of India and Moderna. The Africa CDC has confirmed 10,444 cases; nine cases and two deaths have been reported in Kenya, and one case in Nigeria. A British healthcare worker infected in the DRC is being evacuated to the UK in a stable condition, with the risk to the UK public described as low.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.